DEVELOPMENT JOURNEY TO REPLACE NEURONS LOST TO ALZHEIMER’S DISEASE WITH NEURAL PRECURSOR CELLS DERIVED FROM SKIN CELLS
With
Professor Michael Valenzuela,
Founder and Chief Scientific Officer,
Skin2Neuron
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | June 2026
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
He studied psychology at the University of New South Wales (UNSW) before completing a PhD on Cognitive Reserve. This work was recognised by one of the nation’s top awards, the Australian Museum Eureka Prize for Medical Research.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
Between 2019-2021 he was employed as a senior advisor to the WHO in one of its flagship Decade of Healthy Ageing initiatives. He also joined the Centre for Healthy Brain Ageing at UNSW as Visiting Professor and played a leading role in the design and successful completion of the Maintain Your Brain – the world’s largest dementia prevention trial that found it is possible to delay cognitive decline in older at-risk people by about 1-year.
Professor Valenzuela is a frequent media commentator and author of the popular science book Maintain Your Brain.
Source: Supplied
-
Research, Mentorship and the PhD Experience
Pancreatic cancer remains one of the deadliest cancers, with survival rates below 10 per cent and treatments often as harsh as the disease itself.
Finding better ways to treat one of the deadliest cancers has become the focus of a University of Wollongong research team, where the relationship between a PhD supervisor and candidate has also played an important role in shaping the next generation of researchers.
-
Imperatives for women diagnosed with ovarian cancer
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.
-
Medical colleges reform to address accessibility, affordability and rural challenges
Australia’s specialist medical colleges are introducing significant changes to their training selection processes to tackle the ongoing shortage of specialist doctors in rural and remote areas. The Council of Presidents of Medical Colleges (CPMC), in collaboration with the National Rural Health Commissioner, has unveiled new guidelines that prioritise candidates with rural backgrounds and experience during trainee selection.
